LJPC insider trading

LA JOLLA PHARMACEUTICAL CO: insider trade history from SEC Form 4 filings.

Total Form 4 trades
451
Last 90 days
0
Buys / sells
42% / 4%
Market cap
—

LJPC insider activity at a glance

FilingIQ tracks 451 insider transactions for LJPC in filings since May 13, 2015. The most recent transaction is dated Aug 22, 2022.

Across the full history, 190 open-market purchases and 17 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on LJPC insider trades is 54.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest LJPC Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Frequently asked

How many insider trades does FilingIQ track for LJPC?
FilingIQ tracks 451 Form 4 insider transactions for LJPC (LA JOLLA PHARMACEUTICAL CO), covering filings from May 13, 2015 onwards. 0 of those are dated within the last 90 days.
Are LJPC insiders net buyers or net sellers?
Across the full Form 4 history for LJPC, 190 transactions (42%) were open-market purchases and 17 (4%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does LJPC insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

Methodology & sources

Every LJPC insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.